Skip to main content
. 2018 Jan 15;7(1):147–159. doi: 10.1007/s40121-017-0184-8

Table 3.

Summary of AEs

Incidence, n (%) n = 19
Any AE 9 (47)
Any AE considered at least possibly related to study medication 0
Any AE leading to discontinuation 0
Any SAE 4 (21)
Any grade 3 or 4 AE 1 (5)
Most common AEs (occurring in > 1 woman)
 Chorioamnionitis 3 (16)
 Vaginal discharge 2 (11)

AE adverse event, SAE serious adverse event